Comparative effectiveness and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in patients with HBV-associated decompensated cirrhosis: insights from a retrospective analysis

Abstract Background HBV infection is a global health issue. Given the severity of decompensated cirrhosis, selecting the most appropriate first-line antiviral medication is crucial for optimizing treatment outcomes and providing the best possible disease control. This retrospective real-world study...

Full description

Bibliographic Details

Published in:	BMC Infectious Diseases
Main Authors:	Lu Chen, Hui-Fang Zhang, Yi-Jing Cai, Lei Zhang, Chao Cai, Ming-Qin Lu, Yue-Ying Zhu
Format:	Article
Language:	English
Published:	BMC 2025-08-01
Subjects:	Decompensated cirrhosis TAF TDF
Online Access:	https://doi.org/10.1186/s12879-025-11473-6